ENDOLOGIX INC /DE/ Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2018-08-22: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; convertible debt; Date of first sale 2018-08-09; Total offering amount $210,500,000.
- 2017-04-07: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Loans, Notes and related Guarantees; Warrants and Common Stock issuable upon exercise of Warrants; Date of first sale 2017-04-03; Total offering amount $179,718,100.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2018-08-22 | Rule 506(b) | Debt; OptionToAcquire; convertible debt | 2018-08-09 | $210,500,000 | $210,500,000 | $0 | 3 |
| 2017-04-07 | Rule 506(b) | Debt; OptionToAcquire; SecurityToBeAcquired; Loans, Notes and related Guarantees; Warrants and Common Stock issuable upon exercise of Warrants | 2017-04-03 | $179,718,100 | $179,718,100 | $0 | 4 |